#5 - Medifast (NYSE:MED)
Next on this list of oversold stocks is Medifast Inc. (NYSE: MED). The company is in the weight loss sector. However, it addresses the problem in the "old school" way. That means it sells weight loss foods and beverages under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.
MED stock is down 66% in the past 12 months and 55% in 2024 alone. It's not hard to understand why. Over the last year, multiple companies have come to market with GLP-1 obesity drugs that are changing the way many people are addressing weight loss. Investors can see this shift in Medifast's revenue and earnings, which are down sharply year-over-year.
MED stock checks in with an RSI of 36.57. This indicates that after the steep sell-off in the last 12 months, buyers may sense that the stock is creating some value. Analysts generally agree. They still have a consensus Hold on the stock, but price targets suggest an upside for patient investors.
About Medifast
Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.
Read More - Current Price
- $18.44
- Consensus Rating
- Reduce
- Ratings Breakdown
- 0 Buy Ratings, 1 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $49.75 (169.8% Upside)
